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Increasing evidence indicates that tissue transglu-
taminase (tTG) plays a role in the assembly and remod-
eling of extracellular matrices and promotes cell adhe-
sion. Using an inducible system we have previously
shown that tTG associates with the extracellular matrix
deposited by stably transfected 3T3 fibroblasts overex-
pressing the enzyme. We now show by confocal micros-
copy that tTG colocalizes with pericellular fibronectin
in these cells, and by immunogold electron microscopy
that the two proteins are found in clusters at the cell
surface. Expression vectors encoding the full-length tTG
or a N-terminal truncated tTG lacking the proposed fi-
bronectin-binding site (fused to the bacterial reporter
enzyme b-galactosidase) were generated to characterize
the role of fibronectin in sequestration of tTG in the
pericellular matrix. Enzyme-linked immunosorbent as-
say style procedures using extracts of transiently trans-
fected COS-7 cells and immobilized fibronectin showed
that the truncation abolished fibronectin binding. Sim-
ilarly, the association of tTG with the pericellular ma-
trix of cells in suspension or with the extracellular ma-
trix deposited by cell monolayers was prevented by the
truncation. These results demonstrate that tTG binds to
the pericellular fibronectin coat of cells via its N-termi-
nal b-sandwich domain and that this interaction is cru-
cial for cell surface association of tTG.
The 80-kDa tissue transglutaminase (tTG)1 is a member of a
family of Ca21-dependent enzymes which catalyze the forma-
tion of cross-links between the g-carboxamide group of peptide-
bound glutamine residues and either the amino groups of pri-
mary amines such as putrescine and cadaverine or the e-amino
group of peptide bound lysine residues (1–3). Although initially
believed to be an intracellular enzyme, there is growing evi-
dence for the involvement of tissue transglutaminase in the
assembly and stabilization of the pericellular matrix of cells
(4–7) and of various extracellular matrices including basement
membranes (8, 9). It has also been shown that the tissue-type
enzyme binds to the extracellular matrix with high affinity (10)
independently of its cross-linking activity (11, 12). Unlike the
other members of the transglutaminase protein family, tTG is
a GTP/GDP-binding protein which shows minimal transglu-
taminase activity in the GTP/GDP-bound form (13, 14). In the
intracellular environment its binding to these nucleotides con-
sequently prevents Ca21 activation of the enzyme (15), consist-
ent with an extracellular function (16). Despite the growing
evidence for an extracellular role for tTG, the enzyme presents
the features of a cytosolic protein such as N-terminal acetyla-
tion, lack of disulfide bridges, and lack of glycosylation (17, 18).
A further feature of this protein and other members of this
protein family with an extracellular function including factor
XIIIa is the lack of a classical leader sequence necessary for the
translocation of proteins into the endoplasmic reticulum for
their secretion (19). It is conceivable that tTG is released pas-
sively from cells through stress-induced transient ruptures in
the plasma membrane or it may be actively secreted by one of
the more recently proposed alternative mechanisms (for re-
view, see Ref. 3).
A number of studies (10, 11, 20) have shown a high affinity of
tTG for fibronectin and a putative fibronectin-binding site has
been localized on tTG (21). Cell culture experiments have in-
dicated that polymerization of fibronectin by cells is promoted
by cell surface-associated tTG (4, 7, 20, 22, 23). Antisense
experiments (23) have also suggested that the cross-linking of
cell surface-associated fibronectin by tTG may be related to the
proposed role for the enzyme in cell adhesion and spreading
(24), in agreement with the observation that adhesion and
spreading of cells on a fibrin-fibronectin matrix formed with a
mutant fibronectin lacking its transglutaminase cross-linking
site is greatly reduced as compared with a matrix formed with
wild type fibronectin (25). These findings together with the
reported close association of tTG and fibronectin in confluent
cell monolayers as detected by immunocytochemistry (Ref. 20,
and references therein) raise the possibility that the external-
ization of tTG from cells could be associated with the assembly
of fibronectin fibrils.
To study the relationship between fibronectin and cell sur-
face association of tTG, two lines of investigation were under-
taken. In the first, a Swiss 3T3 cell line stably transfected with
the cDNA of tTG under the control of a tetracycline inducible
promoter (20) was used to establish colocalization of tTG and
fibronectin at the cell surface on the ultrastructural level. In
the second, fusion proteins between tTG and the bacterial
reporter enzyme b-galactosidase were engineered, one of which
carried a truncated tTG which lacked the first seven N-termi-
nal amino acids. These amino acids have been proposed by in
vitro analysis to be essential for fibronectin binding (21). COS-7
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cells transiently expressing the fusion constructs provided a
tool to analyze the dependence of the cell surface-associated
tTG pool on the integrity of its binding site for fibronectin. Our
results demonstrate that the introduced deletion abolishes
binding of the enzyme to fibronectin and prevents its cell sur-
face localization. We conclude that an intact N-terminal do-
main of tTG is required for its association with the extracellu-
lar matrix.
EXPERIMENTAL PROCEDURES
Cell Culture—Swiss 3T3 fibroblasts, COS-7, and endothelial ECV304
cells were obtained from the European Collection of Animal Cell Cul-
tures and cultured in Dulbecco’s modified Eagle’s medium (DMEM)
complemented with 10%(v/v) fetal calf serum, 2 mM glutamine, 20
units/ml penicillin, and 20 mg/ml streptomycin (Sigma, United King-
dom). The Swiss 3T3 cell line which was inducible for tTG under a
tetracycline regulatable promoter was grown in DMEM containing 10%
(v/v) fetal calf serum, 2 mM glutamine, 20 units/ml penicillin, 20 mg/ml
streptomycin, 400 mg/ml geneticin, 250 mg/ml xanthine, 15 mg/ml hy-
poxanthine, 10 mg/ml thymidine, 2 mg/ml aminopterin, and 10 mg/ml
mycophenolic acid (Sigma). The cells were usually cultured in the
presence of 2 mg/ml tetracycline when no induction of tTG was required
(20).
ELISA—The presence of tTG antigen in conditioned culture medium
was investigated using a modification of the quantitative ELISA
method of Achyuthan et al. (26). The plates were precoated with
3%(w/v) bovine serum albumin in PBS for 1 h at 37 °C prior to the assay
as an additional step. Culture supernatants were concentrated approx-
imately 10-fold on 30-kDa cut-off columns (Falcon Ltd., Oxford, United
Kingdom) prior to assay.
Immunocytochemistry—Stably transfected Swiss 3T3 cells (20)
which had been induced to express tTG by withdrawal of tetracycline
from the culture medium for 72 h were seeded on glass slides and
incubated overnight to obtain a subconfluent monolayer. Cells were
fixed in 1% (w/v) paraformaldehyde in PBS for 15 min, blocked for 1 h
in 3% (w/v) bovine serum albumin in PBS, and incubated overnight at
4 °C with a mixture of primary antibodies in blocking solution. The
primary antibodies used were Cub7402 (Neomarkers, Union City, CA),
a mouse monoclonal antibody targeting the active site of tTG (27) and
rabbit polyclonal antibodies against fibronectin (Sigma). A similar
method was used for immunostaining of transiently transfected COS-7
cells using a mouse monoclonal antibody to b-galactosidase (Promega)
with the exception that cells were permeabilized in 0.1% Triton X-100 in
PBS for 15 min prior to blocking. After thorough rinsing in PBS,
secondary antibodies, fluorescein isothiocyanate-conjugated anti-
mouse, and tetramethylrhodamine isothiocyanate (TRITC)-conjugated
anti-rabbit (DAKO) were applied for 2 h at room temperature. Slides
were rinsed in PBS, mounted in Vectashield mountant (Sigma), and
examined on a LEICA laser confocal microscope.
Immunogold Electron Microscopy—Cells were cultured to confluency
on 0.5-cm squares of Melinex, previously conditioned by overnight in-
cubation in serum containing DMEM. For immunolabeling of tTG in the
ECM, cultures were labeled prior to fixation by addition of monoclonal
antibody Cub7402 into the culture medium at a final dilution of 1/300
for 2 h (20). Unbound antibodies were removed by extensive rinsing in
PBS and cells were then fixed in 1% (w/v) paraformaldehyde and 0.05%
(w/v) glutaraldehyde in PBS, dehydrated through increasing concentra-
tions of ethanol and placed in hydrophilic resin (LRGold resin and
glycolmethacrylate (low acid) (6:4), plus 0.1% bezoinethylether (Taab,
Berks, UK)). Following several changes of resin, the samples were
placed in plastic molds and embedded by polymerization of the resin
using ultraviolet light (360 nm) (under nitrogen gas) for 24 h at room
temperature. The Melinex support was removed to allow for vertical
sectioning of the cells. Ultrathin sections (60–90 nm) were collected on
collodion (2% w/v in amyl acetate)-coated nickel grids. Sections were
blocked for nonspecific binding with 0.5% (w/v) bovine serum albumin
in TBS (20 mM Tris/HCl, pH 7.6, 225 mM NaCl) prior to being exposed
to the primary antibody as indicated. Fibronectin was detected with
rabbit polyclonal anti-fibronectin antibodies (Sigma) diluted 1/200 in
blocking solution. For labeling of intracellular tTG, sections were also
incubated with mouse monoclonal anti-tTG antibody (Cub7402) diluted
1/500 in blocking buffer containing 0.1% (v/v) Tween 20. Grids were
then incubated with the respective colloidal gold-conjugated secondary
antibodies (BioCell, Cardiff, UK), a goat anti-rabbit antibody (5-nm gold
conjugate, diluted 1/200), and a goat anti-mouse antibody (15-nm gold
conjugate, diluted 1/100). The grids were silver enhanced (Silver En-
hancement Kit, BioCell), prior to counterstaining, with 2% aqueous
uranyl acetate and alkaline lead citrate. Samples were viewed on a
JEOL transmission electron microscope (100 CX-II).
Generation of tTG-b-Galactosidase Fusion Constructs—Fusion pro-
tein constructs were engineered by subcloning the human tTG cDNA
into the KpnI restriction site of the pCHK vector which was designed to
fuse proteins with the enzyme b-galactosidase (28). The following prim-
ers were used to amplify by PCR the complete tTG cDNA, with bold
letters indicating the KpnI restriction site added to the cDNA to allow
subcloning into pCHK: sense primer, 59-CAGTGGTACCCATGGCCG-
AGGAGCTG-39; antisense primer, 59-TGAGGTACCGTGGCGGGGCC-
AATGATGAC-39. To amplify a truncated tTG cDNA which lacked its
first 21 bases, the following sense primer was used together with the
above antisense primer: 59-CGATGGTACCCAGGTGTGATCTGGAG-
39. The PCR reactions were carried out with 2.5 units of Taq DNA
polymerase (Roche Molecular Biochemicals) and 0.3 mg of DNA tem-
plate (pSG5/hTG-1 kindly provided by Dr. Peter J. A. Davies, Houston,
TX) in a total volume of 100 ml containing 1.25 mM of each dNTPs and
60 pmol of each primer. The PCR cycles were 1 min at 95 °C (denatur-
ation), 1 min at 60 °C (annealing), and 1 min at 72 °C (elongation) for a
total of 30 cycles. The PCR products were cleaved with KpnI and ligated
following standard protocols. The engineered constructs were se-
quenced to confirm proper integration of the cloned DNA fragment and
the absence of mutations in the PCR amplified tTG coding sequence.
Transient Transfection of COS-7 Cells with Fusion Constructs—
Transient transfection of COS-7 cells with the generated plasmids
(pCHKTG, pCHKTG/DN) and the control pCHK was carried out using
30 ml of the transfection reagent DOTAP (Roche Molecular Biochemi-
cals) and 5 mg of plasmid DNA per 28.3 cm2 of cells following the
manufacturer’s instructions. Cells were grown on plastic to 80% con-
fluency for transfection and transfected cells were cultured for another
48 h in 5% CO2 at 37 °C in phenol red-free culture medium before being
processed for different assays as indicated. Transfection efficiencies
were calculated by determining the number of transfected cells using
the b-galactosidase in situ staining system (Promega) according to the
manufacturer’s instructions. Transfection efficiencies were established
from parallel cultures (duplicates) to the experimental cultures in every
experiment.
Preparation of Cell Extracts—Transiently transfected COS-7 cells
were harvested by trypsinization in PBS containing 5 mM EDTA and
extracted by sonication in 0.25 M sucrose, 2 mM EDTA, 5 mM Tris-HCl,
pH 7.4, and protease inhibitors: 1 mg/ml pepstatin, 1 mg/ml leupeptin, 1
mM phenylmethylsulfonyl fluoride. Cells were cleared from particulate
material by centrifugation at 10,000 3 g for 5 min.
SDS-PAGE and Immunoblotting—Western blot analysis was per-
formed following standard procedures (29). Proteins were separated in
8% SDS-polyacrylamide gels under reducing conditions and transferred
to a nitrocellulose membrane. b-Galactosidase and fusion proteins were
detected using a mouse monoclonal antibody against b-galactosidase
(Promega). A horseradish peroxidase-conjugated anti-mouse antibody
was used in combination with the ECL kit (Amersham International
Plc.) to develop the blots.
Binding of tTG Fusion Proteins to GTP-Agarose—Cell extracts from
2 3 106 transiently transfected COS-7 cells were clarified by centrifu-
gation at 20,000 3 g for 20 min. The resultant supernatant (150 ml
containing approximately 2000 mg of protein) was incubated with GTP-
agarose previously washed and equilibrated in 50 mM Tris-HCl, pH 7.5
(volume of GTP-agarose used, equivalent to 0.5 ml of original suspen-
sion) (Sigma), and then incubated overnight at 4 °C with gentle shak-
ing. The agarose beads were pelleted by centrifugation, the supernatant
removed, and the beads washed twice in cold (4 °C) 50 mM Tris buffer,
pH 7.5, and once more in PBS. The washed beads were boiled in 2 3
strength Laemmli sample buffer for 5 min to solubilize GTP-binding
proteins and the extracted proteins were then fractionated by SDS-
polyacrylamide gel electrophoresis as described above. Gel loadings
were adjusted to take differences in transfection efficiency into account.
Determination of b-Galactosidase Activity—The reaction was per-
formed by incubation of samples in b-galactosidase assay buffer (120
mM Na2HPO4, 80 mM NaH2PO4, 2 mM MgCl2, 100 mM b-mercaptoeth-
anol, 1.33 mg/ml o-nitrophenyl-b-D-galactopyranoside (Promega) at
37 °C for 1 h. The hydrolysis of the b-galactosidase substrate o-nitro-
phenyl-b-D-galactopyranoside into o-nitrophenol was assessed by meas-
uring the absorbance at 420 nm. Standards were made up in DMEM
without phenol red following the kit’s instructions (Promega). Knowing
the corresponding transfection efficiency (see above), the specific b-ga-
lactosidase activity for each cell extract could be calculated and is given
in b-galactosidase milliunits per 100,000 transfected cells.
Binding of tTG Fusion Proteins to Immobilized Fibronectin—150 ml
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extract of transfected COS-7 cells was diluted to 500 ml with PBS and
incubated on a fibronectin-coated plastic surface (24-well tissue culture
plates (Corning) coated overnight with 10 mg/ml fibronectin in 50 mM
Tris-HCl, pH 7.4) for 2 h at 37 °C. The plates were thoroughly rinsed
with PBS and bound b-galactosidase activity measured as described.
Detection of Cell Surface-associated Pool of tTG Fusion Proteins—
COS-7 cells were cultured in 10-cm dishes and transfected as described.
The conditioned culture media were harvested, centrifuged at 800 3 g
for 5 min to eliminate any cell debris, and analyzed for b-galactosidase
activity (see below). The cells were recovered by brief trypsinization and
immediately resuspended in serum containing medium to stop further
protease action. Cells were collected by centrifugation, resuspended in
1 ml of serum-free DMEM, and counted. After incubation in suspension
for a total of 30–35 min, the cells were fixed in 3.7% (w/v) paraformal-
dehyde in PBS for 15 min at room temperature. The fixed cells were
washed 3 times in culture medium and finally resuspended in 150 ml of
phenol red and serum-free DMEM. The cell suspensions, as well as the
harvested media, were analyzed in the b-galactosidase enzyme assay
described above with b-galactosidase standard solutions prepared in
phenol red and serum-free DMEM. After a 1-h incubation at 37 °C, the
cells were pelleted and the absorbance of the supernatant and the
conditioned media were measured at 420 nm. To check the membrane
integrity of the cell preparation, the fixed cells were incubated for 10
min at room temperature in a solution of trypan blue (Sigma) diluted
1/4 in PBS and analyzed for exclusion of the dye.
Detection of tTG Fusion Proteins in Extracellular Matrix Struc-
tures—Adherent transfected COS-7 cells (180,000 cells were originally
plated out in 6-well plates for each assay) were rinsed with PBS before
solubilization in 0.1% deoxycholate in PBS containing 5 mM EDTA. The
remaining ECM on the plastic surface was washed thoroughly with
PBS containing 5 mM EDTA and the associated b-galactosidase activity
was determined as described above.
RESULTS
Assessment of tTG Secretion into Culture Supernatants
Initial investigations were undertaken to assess any direct
secretion of tTG into the growth medium of cells expressing
high levels of the enzyme either constitutively or after trans-
fection with an expression construct. Cells chosen for this study
included stably transfected Swiss 3T3 fibroblasts in which tTG
expression is under control of the tetracycline regulatable pro-
moter (20) and the human endothelial cell line ECV304 (23).
Immunochemical analysis by quantitative ELISA was con-
ducted on concentrated culture medium and did not reveal any
detectable levels of tTG (data not shown). Since it has previ-
ously been shown that tTG is present at the surface of cells in
suspension (4, 23) but is only released on the basal side of
adherent cells (7), the experiment was repeated with cells that
were trypsinized and kept in suspension in serum-free medium
(to prevent scavenging of the enzyme by serum components
including fibronectin) for 3 h at 37 °C. Although tTG has been
shown by several authors to be implicated in the processing of
the pericellular matrix in different cell types by providing
evidence for its activity at the cell surface (4–7, 20, 23), several
replicates of ELISA on the conditioned culture medium showed
that there is no detectable secretion of tTG under these condi-
tions from either cell type (data not shown). tTG binds with
high affinity to ECM proteins, and in particular to cell surface-
associated fibronectin (10) which could result in sequestration
of tTG at the cell surface and prevent it from being released
into the culture medium. This is consistent with the fact that
cells are known to contain a pericellular coat of fibronectin
which is very rapidly re-established after trypsin treatment
(less than 1 h) or which might only be partially removed by
proteolytic cleavage (30).
Immunochemical Analysis of Cell Surface-associated
tTG and Fibronectin
A logical working hypothesis is that tTG is released to the
cell surface but effectively and tightly bound at the cell surface,
as suggested by the presence of tTG activity at the cell surface
but its absence in the culture medium. To test this hypothesis,
immunocytochemical analysis of the cell surface was under-
taken on stably transfected Swiss 3T3 cells which had been
induced by withdrawal of tetracycline from the medium for
72 h to obtain a maximal level of tTG expression. These cells
together with their non-induced controls were seeded at low
density on culture slides 12 h prior to fixation and labeled with
antibodies to tTG and fibronectin without permeabilization.
We have previously shown that these cells secrete fibronectin
and over time elaborate fibronectin fibrils on their surface as
FIG. 1. Detection of cell surface-related tTG and fibronectin antigen in stably transfected Swiss 3T3 fibroblasts induced and
non-induced for overexpression of tTG. Panels A, B, and C show the immunostaining patterns of the same field for non-induced (1tetracycline)
cells, whereas D, E, and F show the respective patterns of the same field for induced cells (2tetracycline). For immunostaining, cells were fixed
but not permeabilized to detect pericellular antigen. Cells were stained with a mouse monoclonal anti-tTG antibody using an fluorescein
isothiocyanate-conjugated secondary antibody (A and D), and rabbit polyclonal antibodies to fibronectin using a secondary antibody conjugated to
rhodamine (B and E). Panels C and F show the areas of colocalization of tTG and fibronectin in an orange/yellow color in the superimposed images.
Pictures were taken on a laser scanning confocal microscope and micrographs represent an extended focus view calculated from 0.5-mm section
planes. The bar in panel E indicates 10 mm.
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part of the organization of their ECM (20). Detection of tTG and
FN in the induced non-confluent cells showed a punctate pat-
tern of staining which seemed to colocalize (Fig. 1). In the
non-induced cells, which showed negligible cell surface staining
for tTG, FN staining did not appear altered (Fig. 1). This result
showed first of all that tTG is detectable at the cell surface, and
second, it showed a close association between tTG and fibronec-
tin during the early stages of the organization of a pericellular
fibronectin matrix.
This close association of tTG with fibronectin at the cell
surface as shown by confocal microscopy was further confirmed
when stably transfected 3T3 cells induced to overexpress tTG
were analyzed at the electron microscope level using immuno-
gold labeling (Fig. 2). Specific intracellular labeling for tTG and
fibronectin was obtained as well as in the pericellular matrix of
the cells. In the case of tTG, detection of the enzyme in the
pericellular matrix was only made possible by addition of the
primary antibody to live cells in culture prior to fixation and
embedding, suggesting that the epitope of the enzyme recog-
nized by the monoclonal antibody becomes occluded or de-
stroyed during the processing techniques for immunogold la-
beling. We have previously used this technique to detect
extracellular tTG by immunofluorescence in non-induced and
induced transfected cells (20) which indicated very little label-
ing in the non-induced cells thus demonstrating the specificity
of the antibodies for tTG in live cultures. Moreover detection of
the enzyme by this methodology illustrates that its extracellu-
lar location is not a result of leakage of the enzyme from cells
during the fixation and processing procedure. Labeling of tTG
using a secondary antibody conjugated to 15-nm gold particles
indicated enzyme clusters present at both the basal and apical
surfaces with high density staining at cell surfaces involving
overlapping cells (Fig. 2A). Labeling of fibronectin using a
secondary antibody conjugated to 5-nm gold particles showed a
close colocalization of this protein with tTG (Fig. 2, A and B).
The presence of dense clusters of gold particles containing both
tTG and fibronectin that were closely associated with the cell
surface (see arrows Fig. 2A) was revealed and could represent
cell surface assembly sites of fibronectin (22). Fig. 2B which
represents a larger cytoplasmic area for two fibroblasts as
opposed to Fig. 2A which shows an area of several overlapping
cells, indicates as pointed out by the arrowheads that tTG can
be found in association with fibronectin in the intracellular
environment. The significance of this remains, however, un-
clear since the secretory vesicles in which fibronectin is likely
to be found are not clearly discernible because of the type of EM
processing required for immunogold techniques. Moreover ac-
tive translocation of tTG into membrane bound vesicles or
across the plasma membrane has not been shown.
Investigation of the Interaction of tTG with Fibronectin by
Transfection of Cells with Constructs Containing
Full-length and Truncated tTG
Generation of Expression Constructs and Characterization of
Fusion Proteins—A more quantitative method of tracking the
enzyme was sought which would allow the analysis of the
mechanism of interaction between tTG and FN and the influ-
ence of this interaction on the accumulation of the enzyme at
the cell surface. For this purpose, fusion constructs were engi-
neered by subcloning the tTG cDNA into the mammalian ex-
pression vector pCHK resulting in the fusion of the C-terminal
end of the tTG protein to the N-terminal end of b-galactosidase
with the spacer Thr-Val-Pro-Pro between the two proteins. The
pCHK vector allows for high level constitutive expression of
fusion proteins under control of the SV40 promoter. As a fur-
ther means of studying the interaction between tTG and fi-
bronectin, a fusion protein was made which had the first seven
N-terminal amino acids deleted from the tTG protein. These
amino acids were reported by in vitro analysis to be essential to
confer a fibronectin-binding site to the enzyme tTG (21). A
schematic representation of the fusion proteins constructed is
shown in Fig. 3.
Since the activity of b-galactosidase is retained after
paraformaldehyde fixation of cells, determination of b-galacto-
sidase activity using a colorimetric assay could serve as a
simple means of localization and quantification of tTG in dif-
ferent compartments. COS-7 cells were chosen for transient
transfection experiments with the fusion constructs since they
contain very low endogenous levels of tTG (0.3 units/mg of
FIG. 2. Immunogold electron microscopic localization of tTG
and fibronectin in Swiss 3T3 fibroblasts overexpressing tTG.
Ultrathin sections of resin-embedded cell monolayers (vertical section
plane) were labeled using a mouse monoclonal antibody against tTG
and rabbit polyclonal antibodies against fibronectin. Anti-mouse sec-
ondary antibodies conjugated to 15-nm gold particles were used for
revealing tTG and anti-rabbit antibodies conjugated to 5-nm gold par-
ticles for fibronectin. Representative images are shown (warranted by
capture and selection of the images by a person specializing in this
technology but unfamiliar with the research area). Besides a broad
distribution of tTG in the cell cytosol, intense labeling for both tTG and
fibronectin was apparent at the cell surface at basal and apical mem-
branes and intercellular junctions with clusters apparently containing
both proteins being frequently present in these localities (arrows in A).
The inset in panel A shows an enlarged (3 2) region taken from the area
between cells indicated by the arrow while the inset in panel B shows an
enlarged (3 2.2) region taken from the basal side of the cell adjacent to
the enlarged area further demonstrating the close association of the two
proteins at the cell surface. tTG and fibronectin are occasionally also
detected in close proximity in the intracellular environment (arrows in
B). Panels A and B represent images magnified 68,000 times.
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protein) and higher transfection efficiencies can be obtained
with these cells compared with other cell lines such as Swiss
3T3 fibroblasts. The transfection efficiency varied between 5
and 20% throughout the study and was determined and cor-
rected for in each of the subsequent experiments. Correct ex-
pression of the fusion proteins in COS-7 cells was first exam-
ined by Western blot analysis using an anti-b-galactosidase
antibody (Fig. 4). b-Galactosidase in extracts of transfected
cells migrated with an apparent molecular mass of 120 kDa,
whereas the tTG-b-galactosidase fusion proteins showed a mo-
lecular mass of around 200 kDa (the truncated fusion had only
7 amino acids removed, a difference which is undetectable by
SDS-PAGE analysis), in agreement with expectations. Immu-
nocytochemical staining of permeabilized transfected cells with
the anti-b-galactosidase antibodies and the monoclonal anti-
body to tTG gave a coinciding pattern highlighting the trans-
fected cells, thus confirming the immunoreactivity of the fusion
proteins with their respective antibodies and the presence of
the epitope recognized by the monoclonal antibody to tTG on
the fusion proteins in particular (Fig. 5). To ensure that the
b-galactosidase activity was comparable for native b-galacto-
sidase and b-galactosidase fusion proteins, the specific (correct-
ed for transfection efficiency) b-galactosidase activity ex-
pressed by the different constructs in cell lysates was analyzed
and shown to be very similar (Table I).
GTP Binding of tTG Fusion Proteins—Further confirmation
of the structural integrity of tTG and truncated tTG when
fused with b-galactosidase was obtained by their retained abil-
ity to bind GTP. The GTP-binding site has recently been shown
to be part of the catalytic core domain of tTG but to be distinct
from the active center providing the cross-linking activity (31).
Cytosol fractions of cell extracts obtained from COS-7 cells
transiently transfected with pCHK, pCHKTG, and pCH-
KTG/DN were allowed to bind to GTP-agarose overnight. Non-
bound proteins were then eluted from the beads and the bound
proteins recovered from the beads by boiling in SDS sample
buffer and analyzed by SDS-PAGE followed by immunoblotting
with antibodies to b-galactosidase. As shown in Fig. 6, the
fusion proteins synthesized by cells transiently transfected
with the pCHKTG and pCHKTG/DN vectors bound to GTP-
agarose, thus confirming the GTP binding ability of tTG when
part of a fusion protein with b-galactosidase or N-terminally
truncated.
Binding of tTG Fusion Proteins to Fibronectin in Vitro—To
determine whether the full-length and truncated tTG fusion
proteins were able to bind to fibronectin, extracts of transfected
COS-7 cells were incubated on fibronectin-coated plastic sur-
faces and the binding of the fusion proteins was assessed by
determining retained b-galactosidase activity following exten-
sive rinsing as described under “Experimental Procedures” (Ta-
ble II). With extracts obtained from cells transfected with the
full-length tTG construct, significant b-galactosidase activity
was bound on the FN-coated surface. In contrast, with extracts
obtained from cells transfected with the construct containing
the N-terminal-truncated tTG fusion protein, very little activ-
ity was recovered on the fibronectin-coated surface. Since b-ga-
lactosidase activity in the cell extracts was comparable for the
two fusion proteins this suggests that fibronectin binding is
abolished by the introduced N-terminal deletion. This experi-
ment confirms results obtained with denatured proteolytic
fragments of tTG in a solid phase assay (21) and extends these
findings by showing for the first time, using a cellular system,
the importance of the first seven amino acids of tTG in fibronec-
FIG. 3. Schematic representation of engineered tTG-b-galactosidase fusion constructs. The expression vector pCHK encodes for the
bacterial enzyme b-galactosidase (1). By subcloning the tTG cDNA into pCHK as described in detail under “Experimental Procedures,” the vector
pCHKTG was engineered which encodes for a fusion protein of tTG and b-galactosidase linked by the sequence Thr-Val-Pro-Pro (2). pCHKTG/DN
is encoding for a similar fusion protein lacking the first N-terminal 7 amino acids ((Met)Ala-Glu-Glu-Leu-Val-Leu-Glu) of tTG (3).
FIG. 4. Western blot analysis of fusion proteins expressed in
transiently transfected COS-7 cells. Transiently transfected COS-7
cells were extracted by sonication in Tris-buffered saline (containing
EDTA to prevent cross-linking) and proteins were fractionated on a 8%
SDS-PAGE gel under reducing conditions and analyzed by immunoblot-
ting using an anti-b-galactosidase antibody: pCHKTG/DN, lane 1; pCH-
KTG, lane 2; pCHK, lane 3. Lane 4 shows a cell extract from COS-7 cells
that had not been transfected. Purified b-galactosidase was added to
lane 5. The migration position of the tTG-b-galactosidase fusion pro-
teins and b-galactosidase alone are in good agreement with the ex-
pected molecular weight based on their primary structure. The migra-
tion position of molecular weight standards is shown on the right.
FIG. 5. Immunocytochemical analysis of COS-7 cells tran-
siently transfected with the different fusion constructs. Panels A
and B show pCHKTG transfected cells, panels C and D show pCH-
KTG/DN transfected cells. Cells were fixed 48 h post-transfection and
permeabilized to facilitate antigen detection. tTG (A and C) and b-ga-
lactosidase (B and D) were detected using monoclonal antibodies to the
respective proteins and fluorescein isothiocyanate-conjugated second-
ary antibodies. Cell nuclei were stained with propidium iodide. Images
are computer generated after examination on a LEICA laser confocal
microscope. The bar represents 10 mm.
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tin binding for a close to native and therefore physiologically
relevant protein preparation.
Detection of Cell Surface-associated tTG Fusion Protein
Pools in Transiently Transfected COS-7 Cells
The externalization of the tTG fusion proteins from tran-
siently transfected COS-7 cells was assessed by measuring cell
surface-associated b-galactosidase activity using cells in sus-
pension. No b-galactosidase activity was found in the condi-
tioned culture medium for any of the constructs (including
pCHK) in agreement with the initial ELISA analysis of
ECV304 and induced Swiss 3T3 fibroblast-conditioned cell cul-
ture media. To determine cell surface-associated b-galactosid-
ase activity, the cells were first fixed to stop membrane trans-
port mechanisms so that the substrate for b-galactosidase
would not access the intracellular pool of the enzyme. b-Galac-
tosidase activity was assessed by photometric measurement of
the breakdown of o-nitrophenyl-b-D-galactopyranoside and is
shown in Table III. pCHKTG (full-length tTG) transfected cells
express an average of 164% of the control (pCHK expressing
b-galactosidase alone) and pCHKTG/DN (truncated tTG) trans-
fected cells express an average of 82.7% of the control. While
the activity of the b-galactosidase and the truncated fusion
protein-expressing cells is comparable, the difference in activ-
ity of these as compared with the full-length fusion protein-
expressing cells is statistically significant (p # 0.05). The ac-
tivity expressed by the pCHK-transfected control is likely due
to o-nitrophenyl-b-D-galactopyranoside gaining access to a lim-
ited pool of intracellular b-galactosidase in damaged cells. Cells
processed in this way showed that between 85 and 95% were
capable of excluding trypan blue. The higher activity measured
in the pCHKTG-transfected cells is presumably due to cell
surface-associated tTG fusion protein. This suggests that a pool
of the full-length tTG is translocated to the cell surface follow-
ing synthesis. The truncated fusion protein may be absent from
the cell surface either because it is not translocated or because
it fails to bind to the cell surface following translocation due to
the deletion altering its ability to bind fibronectin. However,
the latter appears less likely since no detectable b-galactosid-
ase activity was present in the suspending medium of these
cells. A further possibility which we cannot exclude is that in
the pCHKTG-transfected cells a small fraction of full-length
tTG released from damaged cells becomes surface associated by
binding to the pericellular fibronectin matrix of other cells and
contributes to the observed difference. However, following
trypsinization, cells were immediately suspended in serum con-
taining medium which is likely to scavenge any enzyme re-
leased from damaged cells.
Detection of tTG Fusion Proteins Associated with the
Extracellular Matrix (ECM) of Transiently Transfected
COS-7 Cells
A further experiment was performed to investigate the ex-
ternalization of the tTG fusion proteins in which the extracel-
lular matrix of adherent cells was analyzed (Table IV). In the
remaining ECM after adherent transfected COS-7 cells were
removed by extraction with EDTA (to prevent cross-linking)
and deoxycholate containing buffer, the pCHKTG-transfected
culture showed 12 times the b-galactosidase activity of the
pCHKTG/DN-transfected culture. The data indicates that the
intact tTG fusion protein, unlike the truncated tTG fusion
protein, is deposited into the ECM laid down by the cells. Again
we cannot exclude the possibility that a small fraction of full-
length fusion protein released from cells upon solubilization is
binding to matrix-associated fibronectin. However, the associ-
ation of a pool of the intact tTG fusion protein with the extra-
cellular matrix is consistent with the immunoelectron micro-
scopic localization of a pool of tTG in the extracellular matrix of
cells on sections of monolayers (Fig. 2).
DISCUSSION
Although several reports have provided indirect evidence for
an externalization of tTG by cells and for a pericellular local-
ization of the enzyme through its capacity to cross-link fi-
bronectin and other pericellular proteins (4, 7, 10, 20), the
FIG. 6. GTP binding of tTG-b-galactosidase fusion proteins.
Cytosol fractions from COS-7 cells transiently transfected with the
pCHK, pCHKTG, and PCHKTG/DN vector were incubated with GTP-
agarose. After rinsing, bound proteins were solubilized in Laemmli
sample buffer and separated on a 8% SDS-PAGE gel under reducing
conditions. After transfer to nitrocellulose, fusion proteins were de-
tected with antibodies to b-galactosidase. The migration position of
molecular weight standards is shown on the left.
TABLE I
b-Galactosidase (b-Gal) activity expressed by cells transfected
with the different constructs
COS-7 cells were transiently transfected with the different vectors as
indicated, and transfection efficiency (number of b-galactosidase ex-
pressing cells) and b-galactosidase activity in cell extracts were deter-
mined 48 h post transfection from parallel cultures. The data repre-
sents the mean 6 S.E. of three separate experiments.
Milliunits pCHK PCHKTG pCHKTG/DN
b-Gal/100,000 transfected cells 34 6 6.3 33.3 6 5.26 30.6 6 4.84
TABLE II
Binding of the tTG and the N-terminal truncated tTG fusion proteins
to fibronectin
Fibronectin bound b-galatosidase activity
(milliunits/100,000 transfected cells)
pCHKTG PCHKTG/DN
Experiment 1 0.83 0.12
Experiment 2 0.98 0.32
Experiment 3 1.31 0.03
Mean 1.04 6 0.14 0.16 6 0.08
Cell extracts of COS-7 cells transiently transfected with the indicated
fusion constructs were incubated on fibronectin coated plastic for 2 h at
37 °C (in the presence of EDTA to prevent cross-linking) and after
rinsing, bound b-galatosidase activity was determined.
TABLE III
Cell surface-associated b-galactosidase activity in COS-7 cells
transfected with the different constructs
COS-7 cells were transfected with the indicated constructs and after
48 h, cells were harvested by brief trypsinization. After blocking of
further proteolysis, cells (105) were rinsed and incubated in suspension
in serum-free medium for ;30 min, prior to fixation. b-Galactosidase
activity associated with fixed cells in suspension (exposed on cell sur-
face) was determined. Specific activity is given with numbers in paren-
theses representing percentages of specific b-galactosidase activity for





Experiment 1 0.39 (100%) 0.6 (154%) 0.45 (115%)
Experiment 2 2.56 (100%) 3.39 (132%) 2.19 (85.5%)
Experiment 3 0.63 (100%) 1.37 (217%) 0.3 (47.6%)
Experiment 4 0.24 (100%) 0.37 (154%) NAa
Mean of percentage 100% 164.25% 82.7%
a NA, not applicable.
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mechanism for externalization of tTG and other members of
this protein family with an extracellular function including
factor XIII a-subunit remains unclear (3). Despite the abun-
dance of tTG in the extracellular matrix in tissues (8, 32–34)
and that deposited by cultured cells (6, 7, 20, 35, 36), our
attempts to detect tTG in culture supernatants of cells express-
ing the enzyme at high level either constitutively, endothelial
cells (ECV304), or after induction from an introduced expres-
sion construct, stably transfected Swiss 3T3 fibroblasts, indi-
cated its absence from the conditioned culture media. These
initial experiments together with our previous studies (20)
demonstrating tTG activity at the cell surface and cross-linking
of pericellular fibronectin indicated that in these cells tTG
remained tightly bound to the cell surface after externalization.
The immunocytochemical analysis of the cells using laser scan-
ning confocal microscopy and immunogold electron microscopy
revealed that tTG is found in clusters with FN at the cell
surface (Figs. 1 and 2). To our knowledge, this is the first report
showing the association of the two proteins in situ at the
ultrastructural level. Detection of extracellular tTG protein for
ultrastructural analysis was made possible by addition of the
primary antibody to live cells in culture which eliminates the
well known problem of masking of the epitope in this compart-
ment by fixation procedures (33). The punctate pattern of im-
munostaining at the cell surface, revealed by confocal micros-
copy, for both tTG and FN during the re-establishment of the
pericellular matrix following trypsinization is likely to repre-
sent matrix assembly sites of FN (22) and suggest that tTG
might play a role in FN fibril formation. This observation is
consistent with an earlier study that suggested the association
of tTG with distinct domains of the plasma membrane in hepa-
tocytes that contain FN as determined from isolation of mem-
brane-bound protein complexes (37). These results are also
consistent with a recent study on endothelial cell monolayers
demonstrating that cell surface-associated transglutaminase
activity in polarized cells is restricted to the basolateral surface
(7) where an extracellular matrix is laid down. This suggests
that externalization of tTG may be linked to the deposition and
assembly of extracellular matrices where close association of
the enzyme with one or more matrix proteins e.g. fibronectin, is
an essential part of the externalization mechanism.
The apparent association between tTG and FN at the cell
surface therefore, raised the question whether the interaction
between the two proteins was playing a role in the cell surface
localization of tTG. To address this question, we used fusion
proteins between tTG and the reporter enzyme b-galactosidase
(Fig. 3) for ease of detection of the latter in a quantitative
manner. The fusion of b-galactosidase to the C terminus of tTG
did not interfere with the interaction of tTG and FN (Table II),
consistent with the expectations from data suggesting that the
N terminus of tTG mediates fibronectin binding (21). A high
affinity binding site for tTG on fibronectin has been localized to
a segment constituting the third to fifth type I domain using
rotary shadowing electron microscopy (11), but the nature of
the interaction of the fibronectin type I repeats with the N-
terminal b-sandwich domain of tTG is not known. Using im-
mobilized SDS-denatured tTG proteolytic fragments in overlay
assays, Lorand and co-workers (21) identified the first 7 amino
acids of tTG as the FN-binding site located in the N-terminal
domain. To further characterize the role of this linear peptide
sequence of tTG in the interaction between the two proteins
under more physiological conditions, a truncated fusion protein
was generated lacking the first 7 N-terminal amino acids of
tTG. For this purpose, the tTG cDNA was subcloned into the
expression vector pCHK such that an additional 3 amino acids,
Met-Val-Pro, were generated at the N terminus of tTG in both
constructs (Fig. 3). This N-terminal extension of tTG is unlikely
to affect protein folding of wild-type tTG as suggested by the
N-terminal heterogeneity seen among different transglutami-
nase gene products (3). However, the introduction of these
amino acids in the truncated version of tTG reconstitutes a Val
in position 7 that is believed to be important for proper folding
of the b-sheet of the N-terminal domain (38). Similar to Ala in
wild-type tTG, a Val in the penultimate position is known to
have a stabilizing effect on the translated polypeptide. tTG as
well as factor XIII a-subunit are known to be N terminally
processed by removal of the terminal Met and acetylation of the
penultimate residue (18, 39). Ala and Ser found in this position
in wild-type tTG and factor XIII a-subunit, respectively, unlike
Val in the generated fusion proteins, favor co-translational
N-acetylation (40). While we have not assessed whether or not
the fusion proteins are N-acetylated, it has previously been
shown that the catalytic activity of tTG is not altered by the
absence of N-acetylation (by determining kinetic constants for
cross-linking reaction) (41). Despite the fact that we demon-
strate the expected dual functionality of the fusion proteins and
conservation of epitopes recognized by monoclonal antibodies
for both proteins (Figs. 4–6, Table I), we cannot completely rule
out that the introduced N-terminal truncation leads to an al-
teration in the folding of the N-terminal b-sandwich domain of
tTG resulting in conformational changes in the fibronectin-
binding site rather than its deletion per se. Our results with
these fusion proteins demonstrate not only that the presence of
these 7 amino acids is essential for binding of tTG to FN under
physiological conditions (Table II) but also for the association of
tTG with the cell surface and ultimately the extracellular ma-
trix of transiently transfected COS-7 cells (Tables III and IV).
We cannot exclude that release of tTG from a small number
of damaged or dying cells which are always present in cultures
contributed to the pool of the enzyme found at the cell surface
in the different experiments reported herein. However, it is
likely that both physiologically and in our cell systems, tTG is
externalized through a more efficient mechanism than just
relying on its release from dying neighboring cells. Several
alternative mechanisms for export of proteins synthesized in
the cytosolic compartment have been described and involves
processes ranging from passive diffusion through stress-in-
duced transient ruptures in the plasma membrane to active
transport across the membrane through specialized pores in
the plasma membrane, e.g. formed by members of the multi-
drug resistance protein family (42–45). Typically, proteins be-
longing to this class contain specific post-translational modifi-
cations which presumably constitute signals for export or
facilitate membrane association. N-Acylation may play a role in
sequestration of tTG to the membrane and thus have an impact
on its externalization. In fact, preliminary data suggests the
TABLE IV
b-Galactosidase activity found in the extracellular matrix of cells
transfected with the different constructs
COS-7 cells were transfected with the different fusion constructs as
indicated. After 48 h, the cell layer was removed by extraction with
deoxycholate (in the presence of EDTA to prevent cross-linking), and
b-galactosidase activity bound to the remaining ECM structures was
determined. Numbers in parentheses represent the percentage of b-ga-
lactosidase activity for pCHKTG/DN transfectants assuming 100% ac-




Experiment 1 5.8 (100%) 0.64 (11%)
Experiment 2 10.6 (100%) 0.93 (8.7%)
Experiment 3 2.5 (100%) 0.14 (5.6%)
Mean of percentages 100% 8.4%
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presence of a fatty acid anchor on a fraction of the cellular tTG
pool (46) in analogy to other transglutaminases (47, 48). This
fraction of tTG may well correspond to the membrane-associ-
ated fraction of tTG in the cell (49, 50), translocate across the
plasma membrane by a mechanism that is not understood, and
ultimately through binding to fibronectin constitute the cell
surface-associated tTG activity forming cross-linked complexes
containing fibronectin. It is interesting in this regard that with
the N terminally truncated tTG, the pool of enzyme which was
absent from the cell surface could not be detected in the culture
supernatants. This suggests that the N-terminal domain of tTG
which comprises the fibronectin-binding site is not only re-
quired for association of the enzyme with the cell surface, but
apparently also constitutes a discriminatory signal for efficient
export of the enzyme into the extracellular environment.
While the mechanism for the release of tTG into the extra-
cellular compartment remains to be elucidated, our results
demonstrate that the interaction of tTG with fibronectin is
crucial for its presence at the cell surface. Several lines of
evidence suggest that cell surface-associated tTG plays a role in
cell-substratum interaction. Both, culturing of cells in the pres-
ence of nonpeptidyl inactivators specific for transglutaminases
as well as down-regulation of tTG synthesis by stable transfec-
tion of cells with a tTG antisense construct rendered the cells
susceptible to detachment from the substratum (7, 23). Con-
versely, overexpression of tTG in Balb-c 3T3 fibroblasts in-
creased cell spreading and adhesion of the cells to the substra-
tum (24). Further support for a direct link between the
interaction of tTG with FN and cell adhesion comes from a
recent study where a series of FN variants carrying point
mutations have been generated. The attachment and spreading
of fibroblasts on fibrin clots formed with mutant FN lacking the
major cross-linking site for factor XIII was significantly re-
duced as compared with clots formed with wild-type FN (25).
Since the major amine acceptor sites for cross-linking of FN by
factor XIII and tTG are identical (51), this suggests that the
effect of tTG on cell attachment and spreading is likely to be
mediated by cross-linking of FN which is consistent with the
results obtained with transglutaminase inhibitors. However,
this is not necessarily obvious since high affinity binding sites
for tTG on substrate proteins including fibronectin have been
shown to be distinct from the cross-linking sites (11, 12) and
since band 4.2, a member of this protein family without cata-
lytic activity, has a structural role based on protein-protein
interactions.
In conclusion, our results show that binding of tTG to fi-
bronectin is mediated by its N-terminal b-sandwich domain
and that this interaction is crucial to its presence at the cell
surface and for association with the pericellular matrix of cells.
Taken together with the data in the literature, our results
suggest that tTG through its association and cross-linking of
the pericellular matrix of cells, is an important contributing
factor to cell adhesion. Moreover they also indicate that this
function is mediated in the first instance by the interaction of
the enzyme with cell surface-associated fibronectin.
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